The approval of new antibody medications for Alzheimer's disease—lecanemab and donanemab—and diagnostic tests in the blood mark the beginning of a new era in Alzheimer's disease diagnosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback